These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24887387)

  • 21. Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.
    Gozdzik J; Czogala W; Skoczen S; Krasowska-Kwiecien A; Wiecha O; Mordel A; Lesko E; Majka M; Kowalczyk D; Zembala M
    Pediatr Transplant; 2009 Sep; 13(6):760-5. PubMed ID: 18992055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiation.
    Onishi Y; Mori S; Kusumoto S; Sugimoto K; Akahane D; Morita-Hoshi Y; Kim SW; Fukuda T; Heike Y; Tanosaki R; Tobinai K; Takaue Y
    Int J Hematol; 2007 Apr; 85(3):256-63. PubMed ID: 17483064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haploidentical Bone Marrow Transplantation in 2015 and Beyond.
    Ruiz-Argüelles GJ; Ruiz-Delgado GJ; González-Llano O; Gómez-Almaguer D
    Curr Oncol Rep; 2015 Dec; 17(12):57. PubMed ID: 26467275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
    Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
    Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haematopoietic progenitor cells from adult bone marrow differentiate into cells that express oligodendroglial antigens in the neonatal mouse brain.
    Bonilla S; Alarcón P; Villaverde R; Aparicio P; Silva A; Martínez S
    Eur J Neurosci; 2002 Feb; 15(3):575-82. PubMed ID: 11876786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation.
    Halaburda K; Labopin M; Houhou M; Niederwieser D; Finke J; Volin L; Maertens J; Cornelissen JJ; Milpied N; Stuhler G; Kröger N; Esteve J; Mohty M; Nagler A
    Bone Marrow Transplant; 2018 Jun; 53(6):683-691. PubMed ID: 29670208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.
    Markova M; Barker JN; Miller JS; Arora M; Wagner JE; Burns LJ; MacMillan ML; Douek D; DeFor T; Tan Y; Repka T; Blazar BR; Weisdorf DJ
    Bone Marrow Transplant; 2007 Feb; 39(4):193-9. PubMed ID: 17220905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family caregivers' support needs during allo-HSCT-a longitudinal study.
    Kisch AM; Bergkvist K; Alvariza A; Årestedt K; Winterling J
    Support Care Cancer; 2021 Jun; 29(6):3347-3356. PubMed ID: 33125539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?
    Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Kwan J; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Gottlieb D; Kerridge I
    Support Care Cancer; 2017 Feb; 25(2):421-427. PubMed ID: 27699502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.
    Chang YJ; Zhao XY; Xu LP; Zhang XH; Wang Y; Han W; Chen H; Wang FR; Mo XD; Zhang YY; Huo MR; Zhao XS; Y K; Liu KY; Huang XJ
    J Hematol Oncol; 2015 Jul; 8():84. PubMed ID: 26156584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indications for high-dose therapy and stem cell transplantations].
    Ruutu T
    Duodecim; 1998; 114(12):1249-59. PubMed ID: 11524771
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
    Yu X; Liu L; Xie Z; Dong C; Zhao L; Zhang J; Gu J; Zhu HH
    Crit Rev Oncol Hematol; 2019 Jan; 133():120-128. PubMed ID: 30661648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome.
    Ueno NT; Anagnostopoulos A; Rondón G; Champlin RE; Mikhailova N; Pankratova OS; Zoubarovskaya LS; Semenova EV; Afanasyev BV; O'Brien S; Andreeff M; Zaritskey AY
    Br J Haematol; 2002 Oct; 119(1):131-4. PubMed ID: 12358917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation.
    Hägglund H; Remberger M; Ringden O
    Bone Marrow Transplant; 2014 Dec; 49(12):1541-2. PubMed ID: 25243627
    [No Abstract]   [Full Text] [Related]  

  • 39. Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?
    Chunduri S; Dobogai LC; Peace D; Saunthararajah Y; Quigley J; Chen YH; Mahmud N; Hurter E; Beri R; Rondelli D
    Bone Marrow Transplant; 2008 Jun; 41(11):935-40. PubMed ID: 18264144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Martino R; Parody R; Fukuda T; Maertens J; Theunissen K; Ho A; Mufti GJ; Kroger N; Zander AR; Heim D; Paluszewska M; Selleslag D; Steinerova K; Ljungman P; Cesaro S; Nihtinen A; Cordonnier C; Vazquez L; López-Duarte M; Lopez J; Cabrera R; Rovira M; Neuburger S; Cornely O; Hunter AE; Marr KA; Dornbusch HJ; Einsele H
    Blood; 2006 Nov; 108(9):2928-36. PubMed ID: 16720833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.